Hey! Please calm TF down..lol
I'm just here for the potential of a drug that is one of the few, if only, that can help an intubated COVID-19 patient.
If it has promise, this is an excellent entry point, imo.
But I can't help, from doing a little research, there are some "red flags" here.
Some I am painfully aware of based from previous/current investments.
Slow enrollment means Hot, Sideways Action for months upon months. I would rather wait until the finish line can be clearly seen.
When the last patient is dosed, the clock starts. Investor's will begin to line up to purchase potential lottery tickets, leading to, and hopefully running northbound, into data results.
As for the Red Flags...
I don't like how Dr. Javitt made such grand proclamations without having conducted a study with a control group, the Gold Standard.
Seems reckless and too much about self-promotion.
Hmm.. who does that remind me of?
And to the safety board issue.
While I am aware the good Dr has disputed it, the Politico article is what I am referencing.
Quote... "Politico raised questions about the DSMB’s composition. Javitt, they reported, had picked mask-skeptic Republican congressman Andy Harris and two other acquaintances to run the board, raising concerns from some ethicists who questioned how independent they could be and how qualified they were to assess whether a trial should continue." Endquote.
Just a few issues I'm working through.
I know the risks involved in the OTC, where 90% of investors lose their a**.
Been burned before, just poking around for some info, no need to get too bent outta shape.
LS5
